Drugs / Autologous or Allogeneic tumor cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00722228 | Jul 2008 → Mar 2025 overdue | breast cancer, colorectal cancer, gastric cancer, kidney cancer +3 | Hadassah Medical Organization | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous or Allogeneic tumor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00722228 ↗ |
| Modality | Vaccine | “Five vaccine doses” NCT00722228 ↗ |
| Route | Subcutaneous | “injected subcutaneously” NCT00722228 ↗ |